Beck C, Casey NP, Persiconi I, Moharrami NN, Sike A, Jin Y, Kyte JA(2023) Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy Biomedicines, 11(2) DOI 10.3390/biomedicines11020459, PubMed 36830995
Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A(2023) How I treat endocrine-dependent metastatic breast cancer ESMO Open, 8(2), 100882(in press) DOI 10.1016/j.esmoop.2023.100882, PubMed 36806375
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA(2022) Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial Nat Med, 28(12), 2573-2583 DOI 10.1038/s41591-022-02126-1, PubMed 36482103
